Genzyme Oncology |
Last Update : | 26/December/2011 |
Google PR : | 5 |
Internal links : | 9 |
External links : | 5 |
Archive : | Check how did the site look in the past? |
Human-Computer Interaction Resource Network
Genzyme Oncology |
Last Update : | 26/December/2011 |
Google PR : | 5 |
Internal links : | 9 |
External links : | 5 |
Archive : | Check how did the site look in the past? |
Keyword | Occurrences | Percentage |
---|---|---|
bayer healthcare | 2 | 2.09% |
nasdaq genz | 2 | 2.09% |
genz announced | 2 | 2.09% |
transaction with | 2 | 2.09% |
with bayer | 2 | 2.09% |
Keyword | Occurrences | Percentage |
---|---|---|
nasdaq genz announced | 2 | 3.14% |
with bayer healthcare | 2 | 3.14% |
transaction with bayer | 2 | 3.14% |
mozobil plerixafor injection | 2 | 3.14% |
giving genzyme primary | 1 | 1.57% |
Site IP address : | 164.109.59.22 |
Server type : | Microsoft-IIS/6.0 |
Powered by : | ASP.NET |
Alexa rank : | 5,981,980 |
Description : | Genzymeoncology.com's three-month global Alexa traffic rank is 5,981,980. This site is located in the US. This site has been online since 2003. |
genzyme | 45.50% |
clolar | 13.15% |
clofarabine | 5.48% |
oncology | 4.59% |
genzyme prochymalu | 2.80% |
small molecule therapies | 2.78% |
drug designated healty volunteers | 2.69% |
genzyme webmail | 2.50% |
ilex oncology services incorporated | 2.07% |
gm-csf (leukine) treatment | 1.99% |
Quantcast rank : | 0 | Average US daily traffic : | 0 |
Compete rank : | 3,301,774 |
Average daily unique visitors : | 239 |
MyWot rank : | 0 |
Trustworthiness : | 80 |
Vendor reliability : | 0 |
Privacy : | 0 |
Child safety : | 0 |